US Home - Resources and whitepapers - Whitepapers - Lack of Continuity in the Injectables Market

Lack of continuity of supply in the injectables market and its impact on patient care and hospital costs

Authors

Mary Nazzal, Pharm.D., Clinical IQ, LLC, Eric S. Kastango, MBA, RPh, FASHP, Principal-CEO, Clinical IQ, LLC & CriticalPoint, LLC

Summary

There are 180 drugs in shortage as of July 31, 2018, mostly injectables according to a list on the American Society of Health-System Pharmacists (ASHP) website¹. According to an interactive discussion held at the ASHP Summer Meeting and Exhibition in Denver in 2018, an audience poll showed seventy-seven percent of attendees responded that they were aware of medication errors that occurred at their site based on shortage. Learn how the lack of continuity of supply in the injectables market and its impact on patient care and hospital costs.

You can download the whitepaper by clicking the link below.

Download this whitepaper (PDF)